论文部分内容阅读
Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy
【作 者】
：
【机 构】
：
Key Laboratory of Particle and Radiation Imaging,Tsinghua University, Ministry of Education, Beijing
【出 处】
：
2016年北京市肿瘤放疗年会
【发表日期】
：
2016年5期
其他文献
Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma
The renal cell carcinoma (RCC) is one of the most common types of kidney neoplasia in Western countries;it is relatively resistant to conventional chemotherapy and radiotherapy.Metabolic disorders hav
全脑全脊髓放射治疗在临床上广泛应用于已发生或易于发生中枢神经系统(CNS)播散的颅内肿瘤,如髓母细胞瘤,松果体母细胞瘤,生殖细胞瘤等.因全脑全脊髓放疗照射范围广,治疗过程中会造成不同程度的血小板减少.轻者影响放放疗的顺利进行,进而影响治疗效果;重者则有可能导致自发性颅内出血危及患者生命.医院于2008年7月-2012年6月在给患者进行全脑全脊髓放疗的同时,给予重组人白细胞介素-11(rhIL-11
目的：探讨血管网织细胞瘤术后复发行放射治疗的可行性方法.方法：1例血管网织细胞瘤术后复发患者行适形调强放疗DT=54Gy/30f/6W,1.8Gy/f.结果：过程顺利,治疗结束后定期复查,肿瘤逐渐缩小.结论：放射治疗可作为血管网织细胞瘤术后复发的挽救性治疗.
Objective To guide a better clinical selection of radiation technology in the treatment of Graves ophthalmopathy by comparing the dose distribution and parameters of 3D-CRT technology, IMRT technology
目的：探讨一氧化氮对X线辐射诱导的不同p53基因状态的人肺癌细胞死亡和染色体畸变的双向性影响.方法：p53缺如的人肺癌H1299细胞通过稳定转染wtp53和mp53基因,得到本实验使用的野生型或突变型p53细胞.X线照射前,细胞作用于不同浓度的硝酸异山梨酯(ISDN,一种一氧化氮供体)和/或羧基-2-苯-4,4,5,5-四甲基咪唑-1-氧-3-氧化物(c-PTIO,一种一氧化氮清除剂).细胞敏感性
临床前研究表明大分割放疗可激活免疫应答,但在临床上鲜有探讨.本研究欲探索大分割放疗对恶性肿瘤患者细胞免疫功能的影响,分析其是否可激活患者免疫状态及激活的时间窗问题.
A 40-year-old Chinese female patient with radiation-induced brain necrosis after radiosurgery was treated with bevacizumab at a single dose of 200 mg (3.27 mg/kg) for 6 times, with an interval of 12-1
研究胸腺增生组织、胸腺瘤和胸腺癌中c-KIT蛋白产物的表达情况,探讨其在鉴别胸腺肿瘤良恶性中的价值及其与胸腺肿瘤的WHO病理分型、Masaoka分期、和预后的关系.
Objective This retrospective study investigated the efficacy and safety of bevacizumab treatment for refractory brain edema.Methods Bevacizumab was used for the treatment of 59 cases of brain metastat
Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of n
Purpose: It is important to minimize lung dose during intensity-modulated radiation therapy (IMRT) of non-small cell lung cancer (NSCLC).In this study, IMRT plans with inhomogeneous dose distributions